Polymer Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Sell
246
-403
-62% -$412K 0.04% 513
2026
Q1
$597K Buy
649
+180
+38% +$182K 0.06% 345
2025
Q4
$504K Sell
469
-109
-19% -$104K 0.05% 462
2025
Q3
$441K Buy
+578
New +$430K 0.05% 452

Other funds holding LLY

Polymer Capital Management's LLY Position: Q2 2026 in Review

Polymer Capital Management reduced its Eli Lilly (LLY) stake by 62% in Q2 2026, selling an estimated $412K and leaving 246 shares worth $295K. The position accounts for 0.04% of the portfolio, ranked #513.

Polymer Capital Management first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $597K in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Polymer Capital Management held 246 shares of Eli Lilly worth $295K as of Q2 2026.
  • Polymer Capital Management sold 403 Eli Lilly shares in Q2 2026, an estimated $412K.
  • Eli Lilly made up 0.04% of Polymer Capital Management's portfolio in Q2 2026, its #513 holding.
  • Polymer Capital Management first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • Polymer Capital Management's Eli Lilly position peaked at $597K in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.